Depressive DisordersPTSDAnxiety DisordersEquity and EthicsImplementation & Service DeliveryPsilocybinMDMALSD

Acute and enduring effects of naturalistic psychedelic use among Indigenous peoples in Canada and the United States

This survey study (n=66) explored the effects of naturalistic psychedelic use on recalled psychological distress and trauma symptoms among Indigenous peoples living in the United States and Canada who had experienced racial trauma. The most commonly used psychedelics were psilocybin, MDMA and LSD. Participants recalled experiencing fewer symptoms of depression, anxiety, stress, trauma, symptoms of discrimination, and alcohol use in the 30 days after (vs. before) the psychedelic experience

Authors

  • Alan Davis
  • Thomas Williams
  • Monnica Williams

Published

Canadian Psychology
individual Study

Abstract

Experiences of past and present oppression/discrimination towards Turtle Island’s Indigenous peoples are pervasive, contributing to symptoms of stress and trauma. Psychedelic substances have been shown to be effective for treating multiple disorders; however, there is a lack of research within Indigenous groups. This study examined the effects of naturalistic psychedelic use on recalled psychological distress and trauma symptoms among Indigenous peoples living in the United States and Canada who had experienced racial trauma. Participants were asked to recall a memorable psychedelic experience and report experiences of past racial trauma and retrospective changes in mental health symptoms within a cross-sectional internet-based survey focusing on people of colour in North America. Sixty-six participants (74.3% residents of Canada, 60.6% female, mean age of 35.9 years) self-identified as Indigenous. Participants mostly reported oral intake of psilocybin, 3,4-methylenedioxymethamphetamine, or lysergic acid diethylamide, and reported frequent experiences of ethnic discrimination and high levels of related stress. Participants recalled experiencing fewer symptoms of depression, anxiety, stress, trauma, symptoms of discrimination, and alcohol use in the 30 days after (vs. before) the psychedelic experience. Greater overall changes were recalled following psilocybin consumption, whereas differential effects were found based on Tribal land, reservation, or reserve residency and participant sex. Exploratory analyses suggested that measures of ethnic discrimination, residency, substance consumed, and sex were related to recalled changes in symptoms. As the healing powers of psychedelic medicines gain in mainstream popularity, one must consider the historical contexts, implications, and perspectives of Indigenous peoples. Several reflection questions are recommended to aid psychedelic stakeholders in conducting their work in an allied manner. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

Available with Blossom Pro

Research Summary of 'Acute and enduring effects of naturalistic psychedelic use among Indigenous peoples in Canada and the United States'

Introduction

De La Salle and colleagues situate this study within growing interest in psychedelic-assisted therapies alongside a recognition that Indigenous peoples of North America have long-standing relationships with psychedelic plant medicines and also face pervasive, racially based trauma. Earlier research has shown beneficial effects of psychedelics for conditions such as depression, anxiety, PTSD-like syndromes, and substance misuse, and recent cross-sectional work in people of colour linked acute psychedelic experiences to reductions in racial trauma symptoms. However, modern psychedelic clinical research has had limited representation of Indigenous participants and has not specifically examined psychedelic effects on racial trauma within Indigenous communities. This study therefore set out to examine whether recalled changes in mental health and trauma-related symptoms (comparing the 30 days before versus 30 days after a memorable naturalistic psychedelic experience) were associated with substance type, country of residence, residency on Tribal lands/reservations/reserves, strength of ethnic identity, severity/frequency of discrimination-related stress, and participant sex in a sample of self-identified Indigenous adults in Canada and the United States. The work also aims to frame considerations for culturally respectful research and policy concerning psychedelic medicines for Indigenous peoples.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (15)

Papers cited by this study that are also in Blossom

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)

1015 cited
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials

Fuentes, J. J., Fonseca, F., Elices, M. et al. · Frontiers in Psychiatry (2020)

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Garcia-Romeu, A., Davis, A. K., Griffiths, R. R. et al. · Frontiers in Psychiatry (2020)

121 cited
Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination

Halstead, M., Reed, S., Krause, R. et al. · Clinical Case Studies (2021)

MDMA enhances emotional empathy and prosocial behavior

´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)

Reactions to psilocybin administered in a supportive environment

Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)

Gender differences in the subjective effects of MDMA

Liechti, M. E., Gamma, A., Vollenweider, F. X. · Psychopharmacology (2001)

349 cited
Show all 15 references
Prediction of psilocybin response in healthy volunteers

Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)

Historic psychedelic drug trials and the treatment of anxiety disorders

Weston, N. M., Gibbs, D., Bird, C. I. V. et al. · Depression and Anxiety (2020)

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Williams, T. M., Davis, A. K., Xin, Y. et al. · Drugs Education Prevention and Policy (2020)

Cited By (1)

Papers in Blossom that reference this study

Experiences of psychedelic drug use among people with psychotic symptoms and disorders: Personal growth and mystical experiences

Torre, J. T. L., Gallo, J., Mahammadli, M. et al. · Journal of Psychedelic Studies (2024)

6 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.